Renowned journalist and news anchor Clive Myrie is to interview Chloe Brown, a project worker at Investing in Children (IiC) CiC live on stage at next week’s PharmaTimes Marketer & Communications Team of the Year Awards.
The government has finally published its long-awaited response to the Accelerated Access Review, with plans for a new Accelerated Access Pathway that will open a new channel providing patients with faster access to the most innovative medicines and technologies.
Novartis, Amgen and the Banner Alzheimer's Institute (BAI) have expanded their collaboration to initiate a new study investigating BACE1 inhibitor CNP520 can prevent or delay the onset of Alzheimer's disease symptoms in a high-risk population.
Young people in the UK with ADHD are at “serious risk of social and mental health harm” because they experience some of the “longest and most complicated” delays to diagnosis anywhere in Europe, a group of experts is warning.
An investigational antibody-drug conjugate being developed by GlaxoSmithKline for patients with multiple myeloma has been awarded Breakthrough Therapy Designation from the US Food and Drug Administration.
GlaxoSmithKline and Innoviva say their combination lung therapy Anoro Ellipta has come out on top in a trial pitting its effectiveness in improving lung function against that of Boehringer Ingelheim’s Spiolto Respimat.
Regeneron and Sanofi have unveiled positive new data from a late-stage trial investigating the biologic dupilumab in adults and adolescents 12 years of age and older with severe, steroid dependent asthma.